FIGURE
Figure 1
- ID
- ZDB-FIG-221226-280
- Publication
- Ruzic et al., 2022 - Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 1
The general pharmacophore model for HDAC inhibitors (A) and chemical structures of five FDA-approved HDAC inhibitors (B). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharmaceutics